5-Amino-1MQ is a small-molecule nicotinamide N-methyltransferase (NNMT) inhibitor investigated in adipocyte metabolism, methylation, and NAD-associated cellular research. The original overview of this page asks three questions: NNMT inhibition and methyl-donor biology, adipocyte and metabolic-model questions, and identity, purity, and formulation verification. It is not a peptide, and peptide-lot methods should not be used as a complete identity file for this material.
Editorial review: 17 November 2026. Prepared by Velnacor Research Desk for research-use communication only. Published findings below are attributed to the cited papers. They are not claims about a Velnacor lot and are not instructions for use in people or animals.
NNMT inhibition and methyl-donor biology
NNMT methylates nicotinamide using S-adenosylmethionine (SAM) as a methyl donor and is studied in metabolic and methyl-pool models. Neelakantan and colleagues reported a structure–activity series of small-molecule NNMT inhibitors and identified quinolinium analogues as a promising scaffold (Neelakantan et al., 2017).
A later paper from the same group explicitly named 5-amino-1MQ as a membrane-permeable methylquinolinium NNMT inhibitor. In 3T3-L1 adipocytes, they reported that 5-amino-1MQ reduced intracellular 1-methylnicotinamide (1-MNA), increased NAD+ in a concentration-dependent manner in the range they tested, and reduced lipid accumulation during differentiation. In diet-induced obese mice, they reported a progressive loss of body weight relative to vehicle controls over the treatment period they described, with no significant difference in food intake; they also reported decreases in epididymal white-adipose-tissue mass and size, adipocyte size, and total plasma cholesterol (Neelakantan et al., 2018).
A 2019 paper from the same group used 5-amino-1-methylquinolium, named as the NNMT inhibitor in the methods, in 24-month-old mice after an acute tibialis-anterior injury. The authors reported elevated muscle-stem-cell proliferation and fusion, nearly two-fold greater myofiber cross-sectional area versus controls, a shift toward larger fibers, and an increase of about 70% in peak torque of the injured muscle. In C2C12 myoblasts, they reported enhanced differentiation with supporting changes in the cellular NAD+/NADH redox state (Neelakantan et al., 2019).
Those findings are in vitro and mouse-model observations. They are not a demonstration of a clinical outcome, and they are not a use instruction. NAD-associated context on this site is discussed separately in What Is NAD+?; 5-Amino-1MQ and NAD+ are different materials and should not share a specification file.
Why this is not a peptide lot
5-Amino-1MQ is a small-molecule quinolinium analogue. Peptide identity methods such as sequence coverage or peptide-specific HPLC/MS interpretation do not, by themselves, complete a small-molecule identity file. The brief should name the exact analogue, salt form if stated, and the assay methods actually used for that lot. A purity percentage copied from a peptide template is not a substitute for those records. Third-Party Peptide Testing, Explained and lot traceability still apply as documentation practices, but the methods listed on the report should match a small-molecule material.
Identity, purity, and formulation verification
Formulation, solvent, and solid form belong on the quotation and the label. Neighboring NNMT-inhibitor names, if they appear in a catalog or a methods paper, should be treated as separate identifiers. 5-Amino-1MQ appears in Velnacor’s research-material catalog (internal product record, slug 5-amino-1mq). There is not a standalone public landing page for every catalog name; use the product directory and the COA Library, then confirm the exact name, specification, and current-lot documents in the inquiry. For packing at supply scale, see wholesale peptides.
Selected published literature
- Neelakantan H, Wang HY, Vance V, Hommel JD, McHardy SF, Watowich SJ. Structure–activity relationship for small molecule inhibitors of nicotinamide N-methyltransferase. Journal of Medicinal Chemistry. 2017;60(12):5015-5028. doi:10.1021/acs.jmedchem.7b00389. PubMed 28548833.
- Neelakantan H, Vance V, Wetzel MD, Wang HY, McHardy SF, Paladini RD, Liang Y, Bembenek EP, Angarita B, LaFleur AD, Krishnamachari S, Ottmers SM, Patterson MK, Bui-Nguyen TM, Srivastav SD, Hommel JD, Watowich SJ. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochemical Pharmacology. 2018;147:141-152. doi:10.1016/j.bcp.2017.11.007. PubMed 29155147. Cited as published cell- and mouse-model observations, not as a use instruction.
- Neelakantan H, Brightwell CR, Graber TG, Maroto R, Wang HY, McHardy SF, Fox J, Fry CS, Watowich SJ. Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle. Biochemical Pharmacology. 2019;163:481-492. doi:10.1016/j.bcp.2019.02.008. PubMed 30753815. Methods in this paper name 5-amino-1-methylquinolium as the NNMT inhibitor. Cited as published mouse- and cell-model observations, not as a use instruction.
Sourcing notes for qualified buyers
Velnacor’s stated supply terms for qualified research and business buyers include: every batch is third-party tested; orders usually ship within 24 hours, subject to stock, documentation review, and destination; trial orders can start from one box of ten vials; parcels lost or damaged in transit are eligible for free reshipment or a refund; and neutral packaging is available when required. Velnacor operates its own production base and has a long-standing supply-chain business.
Those points describe documentation and fulfillment. They do not describe a laboratory or biological outcome. For an order-specific review, send the material name, specification, box quantity, and destination through the inquiry list.
Research-use notice. All Velnacor products are intended strictly for laboratory research use only. They are not drugs, supplements, or food, and are not intended to diagnose, treat, cure, or prevent any disease. Not for human or veterinary use. Purchasers must be qualified researchers. This article is educational content for laboratory and business readers. It does not provide dosing, reconstitution, administration, diagnostic, or treatment guidance.